Form D · Biotechnology
SIWA Biotech Corp.
Oklahoma City, OK · CIK 0001657894
Offering snapshot reported Dec 29, 2017 · SEC filing
- Reported sold
- $1.41M Offering amount: $1.41M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $362 Reported outside-investor minimum
- First sale
- Dec 19, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2017 | Initial | $1,410,000 | No comparison | 16 | SEC filing |
| Nov 1, 2016 | Initial | $1,999,998 | No comparison | 13 | SEC filing |
| Nov 12, 2015 | Initial | $5,290,105 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-301986
Source: Form D, filed Dec 29, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jerald Baldwin | Director |
| William M Canfield | Director, Executive |
| J Darren Head | Director |
| Kevin L Moore | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
755 Research Parkway Suite 125
Oklahoma City, OK, 73104
Oklahoma City, OK, 73104